Corteva (CTVA) Financials

$79.74 +0.70 (+0.89%)

As of 01:02 PM Eastern

Annual Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-5,065	-959	681	1,759	1,147	735	907	1,094
Consolidated Net Income / (Loss)	-5,027	-941	701	1,769	1,158	747	919	1,105
Net Income / (Loss) Continuing Operations	-6,775	-270	756	1,822	1,216	941	863	1,204
Total Pre-Tax Income	-6,806	-316	675	2,346	1,426	1,093	1,275	1,688
Total Operating Income	-6,637	-382	508	1,028	1,565	1,774	1,808	2,438
Total Gross Profit	4,339	5,271	5,710	6,435	7,019	7,306	7,379	8,229
Total Revenue	14,287	13,846	14,217	15,655	17,455	17,226	16,908	17,401
Operating Revenue	14,287	13,846	14,217	15,655	17,455	17,226	16,908	17,401
Total Cost of Revenue	9,948	8,575	8,507	9,220	10,436	9,920	9,529	9,172
Operating Cost of Revenue	9,948	8,575	8,507	9,220	10,436	9,920	9,529	9,172
Total Operating Expenses	10,976	5,653	5,202	5,407	5,454	5,532	5,571	5,791
Selling, General & Admin Expense	3,041	3,065	3,043	3,209	3,173	3,176	3,196	3,492
Research & Development Expense	1,355	1,147	1,142	1,187	1,216	1,337	1,402	1,474
Amortization Expense	391	475	682	722	702	683	685	644
Other Operating Expenses / (Income)	992	744	0.00	0.00	-	0.00	0.00	35
Restructuring Charge	694	222	335	289	363	336	288	146
Total Other Income / (Expense), net	-169	66	167	1,318	-139	-681	-533	-750
Interest Expense	418	149	45	30	79	233	233	180
Other Income / (Expense), net	249	215	212	1,348	-60	-448	-300	-570
Income Tax Expense	-31	-46	-81	524	210	152	412	484
Net Income / (Loss) Discontinued Operations	1,748	-671	-55	-53	-58	-194	56	-99
Net Income / (Loss) Attributable to Noncontrolling Interest	38	18	20	10	11	12	12	11
Basic Earnings per Share	($6.76)	($1.28)	$0.91	$2.39	$1.59	$1.04	$1.31	$1.60
Weighted Average Basic Shares Outstanding	-	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Diluted Earnings per Share	($6.76)	($1.28)	$0.91	$2.37	$1.58	$1.03	$1.30	$1.60
Weighted Average Diluted Shares Outstanding	-	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Weighted Average Basic & Diluted Shares Outstanding	-	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Cash Dividends to Common per Share	-	$0.26	$0.52	$0.54	-	$0.62	$0.66	$0.70

This table shows Corteva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-321	-253	419	1,053	-524	-41	652	1,314	-320	-552	720
Consolidated Net Income / (Loss)	-318	-251	423	1,056	-521	-39	656	1,316	-318	-549	723
Net Income / (Loss) Continuing Operations	-315	-231	376	1,056	-519	-50	667	1,382	-308	-537	725
Total Pre-Tax Income	-444	-323	482	1,338	-633	88	784	1,804	-370	-530	858
Total Operating Income	-237	-167	622	1,517	-460	129	805	1,753	-301	181	1,011
Total Gross Profit	944	1,341	1,942	3,194	761	1,482	2,075	3,524	974	1,656	2,533
Total Revenue	2,590	3,707	4,492	6,112	2,326	3,978	4,417	6,456	2,618	3,910	4,905
Operating Revenue	2,590	3,707	4,492	6,112	2,326	3,978	4,417	6,456	2,618	3,910	4,905
Total Cost of Revenue	1,646	2,366	2,550	2,918	1,565	2,496	2,342	2,932	1,644	2,254	2,372
Operating Cost of Revenue	1,646	2,366	2,550	2,918	1,565	2,496	2,342	2,932	1,644	2,254	2,372
Total Operating Expenses	1,181	1,508	1,320	1,677	1,221	1,353	1,270	1,771	1,275	1,475	1,522
Selling, General & Admin Expense	670	735	736	1,054	671	735	751	1,156	725	860	877
Research & Development Expense	335	357	332	357	348	365	335	375	351	413	341
Amortization Expense	174	175	177	174	170	164	162	161	162	159	160
Other Operating Expenses / (Income)	-	-	-	-	0.00	-	0.00	-	7.00	-	52
Restructuring Charge	2.00	241	75	92	32	89	22	79	30	15	92
Total Other Income / (Expense), net	-207	-156	-140	-179	-173	-41	-21	51	-69	-711	-153
Interest Expense	58	62	41	66	66	60	36	52	46	46	36
Other Income / (Expense), net	-149	-94	-99	-113	-107	19	15	103	-23	-665	-117
Income Tax Expense	-129	-92	106	282	-114	138	117	422	-62	7.00	133
Net Income / (Loss) Discontinued Operations	-3.00	-20	47	0.00	-2.00	11	-11	-66	-10	-12	-2.00
Net Income / (Loss) Attributable to Noncontrolling Interest	3.00	2.00	4.00	3.00	3.00	2.00	4.00	2.00	2.00	3.00	3.00
Basic Earnings per Share	($0.45)	($0.35)	$0.60	$1.51	($0.76)	($0.04)	$0.95	$1.92	($0.47)	($0.80)	$1.07
Weighted Average Basic Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Diluted Earnings per Share	($0.45)	($0.35)	$0.60	$1.51	($0.76)	($0.05)	$0.95	$1.92	($0.47)	($0.80)	$1.07
Weighted Average Diluted Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Weighted Average Basic & Diluted Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Cash Dividends to Common per Share	$0.16	-	-	-	-	-	$0.17	-	-	-	$0.18

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	3,613	-2,851	1,700	-198	-2,436	-920	528	2,606
Net Cash From Operating Activities	483	1,070	2,064	2,727	1,711	3,497	4,332	6,812
Net Cash From Continuing Operating Activities	374	-149	2,064	2,769	1,791	3,577	4,634	6,914
Net Income / (Loss) Continuing Operations	-5,027	-941	701	1,822	2,398	1,867	1,756	2,408
Consolidated Net Income / (Loss)	5,027	-941	701	1,769	2,282	1,479	1,868	2,210
Net Income / (Loss) Discontinued Operations	-	-	-	-53	-116	-388	112	-198
Depreciation Expense	2,790	1,599	1,177	1,243	2,446	2,422	2,454	2,406
Non-Cash Adjustments To Reconcile Net Income	5,208	-161	19	-1,117	652	1,762	1,326	1,100
Changes in Operating Assets and Liabilities, net	-4,225	-918	167	821	-3,705	-2,474	-902	1,000
Net Cash From Discontinued Operating Activities	-	-	-	-42	-80	-80	-302	-102
Net Cash From Investing Activities	-505	-904	-674	-362	-1,264	-3,994	-817	-1,086
Net Cash From Continuing Investing Activities	-505	-904	-674	-362	-1,264	-3,994	-817	-1,086
Purchase of Property, Plant & Equipment	-1,501	-1,163	-475	-573	-1,210	-1,190	-1,194	-1,182
Acquisitions	-8.00	-20	-1.00	-4.00	-96	-2,976	-14	-40
Purchase of Investments	-1,257	-138	-995	-204	-688	-296	-162	0.00
Divestitures	78	270	83	75	146	114	10	108
Sale and/or Maturity of Investments	2,186	160	721	345	590	378	260	104
Other Investing Activities, net	-3.00	-13	-7.00	-1.00	-6.00	-24	283	-76
Net Cash From Financing Activities	-2,624	-2,929	303	-1,266	-2,327	-137	-2,801	-3,288
Net Cash From Continuing Financing Activities	3,744	2,357	1,199	-2,563	-2,327	-137	-2,801	-3,417
Repayment of Debt	-6,422	-6,758	-1,469	-1,800	-3,823	-5,850	-5,825	-3,825
Repurchase of Common Equity	0.00	-25	-275	-950	-1,000	-756	-1,009	-1,071
Payment of Dividends	-2,806	511	-448	-397	-418	-439	-2,337	-2,157
Issuance of Debt	1,156	-867	2,439	484	2,738	6,846	6,250	3,460
Other Financing Activities, net	5,448	9,496	56	100	176	62	120	176
Other Net Changes in Cash	-	-88	7.00	-	-556	-286	-186	168
Cash Interest Paid	923	263	36	30	150	468	488	382
Cash Income Taxes Paid	961	234	229	341	934	1,070	1,414	1,500

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-1,014	749	-2,288	254	1,230	1,332	-2,254	44	840	3,976	-5,168
Net Cash From Operating Activities	-105	7,829	-5,222	536	-114	9,494	-4,218	1,894	386	8,750	-5,782
Net Cash From Continuing Operating Activities	-94	7,919	-5,216	848	-118	9,482	-4,202	1,924	396	8,796	-5,770
Net Income / (Loss) Continuing Operations	-315	695	757	2,122	-1,024	-99	1,334	2,764	-616	-1,074	1,450
Consolidated Net Income / (Loss)	-318	481	851	2,122	-1,028	-77	1,312	2,632	-636	-1,098	1,446
Net Income / (Loss) Discontinued Operations	-3.00	-214	94	-	-4.00	22	-22	-132	-20	-24	-4.00
Depreciation Expense	306	1,523	614	624	612	604	592	602	600	612	594
Non-Cash Adjustments To Reconcile Net Income	174	1,232	504	450	406	-34	206	544	304	46	498
Changes in Operating Assets and Liabilities, net	-222	2,701	-7,091	-2,348	-112	9,011	-6,334	-1,986	108	9,212	-8,312
Net Cash From Discontinued Operating Activities	-11	-50	-6.00	-312	4.00	12	-16	-30	-10	-46	-12
Net Cash From Investing Activities	-229	-4,228	-902	-70	-322	115	-68	-328	-314	-376	-154
Net Cash From Continuing Investing Activities	-263	-2,221	-902	-70	-322	115	61	-328	-314	-505	-154
Purchase of Property, Plant & Equipment	-162	-778	-296	-228	-308	-362	-188	-236	-314	-444	-162
Acquisitions	-20	-1,489	-	-	-14	-	0.00	-	-	-26	-6.00
Purchase of Investments	-76	-213	-264	-8.00	-2.00	-14	0.00	-	-	-	0.00
Divestitures	-26	72	10	30	-36	6.00	16	34	2.00	56	0.00
Sale and/or Maturity of Investments	21	209	14	146	100	126	124	-112	12	80	16
Other Investing Activities, net	-	-22	-366	-10	-62	359	109	-14	-	-171	-2.00
Net Cash From Financing Activities	224	-3,778	3,898	-130	1,612	-8,181	1,990	-1,616	734	-4,396	778
Net Cash From Continuing Financing Activities	-671	-2,845	3,898	-130	1,612	-8,181	1,861	-1,616	734	-4,396	778
Repayment of Debt	-1,869	-3,567	-416	-1,519	-1,172	-2,718	-74	-665	-1,572	-1,514	-92
Repurchase of Common Equity	-253	-171	-252	-252	-253	-252	-270	-250	-250	-301	-250
Payment of Dividends	-114	-112	-112	-111	-117	-1,997	-629	-491	-494	-543	-492
Issuance of Debt	1,563	971	4,662	1,712	3,150	-3,274	2,764	-280	3,040	-2,064	1,578
Other Financing Activities, net	2.00	34	16	40	4.00	60	70	70	10	26	34
Other Net Changes in Cash	-	-	-62	-82	54	-96	42	94	34	-2.00	-10

This table presents Corteva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	217,366	42,397	42,649	42,344	42,618	42,996	40,825	42,845
Total Current Assets	45,944	13,519	14,768	15,546	16,795	16,260	15,097	17,335
Cash & Equivalents	4,540	1,764	3,526	4,459	3,191	2,644	3,106	4,521
Short-Term Investments	10	5.00	269	86	124	98	63	9.00
Accounts Receivable	10,520	5,528	4,926	4,811	5,701	5,488	5,676	6,371
Inventories, net	10,620	5,032	4,882	5,180	6,811	6,899	5,432	5,667
Other Current Assets	2,076	1,190	1,165	1,010	968	1,131	820	767
Plant, Property, & Equipment, net	9,088	4,546	4,396	4,329	4,254	4,287	4,099	4,220
Plant, Property & Equipment, gross	14,680	7,872	8,253	8,364	8,551	8,956	9,074	9,551
Accumulated Depreciation	5,592	3,326	3,857	4,035	4,297	4,669	4,975	5,331
Total Noncurrent Assets	162,334	24,332	23,485	22,469	21,569	22,449	21,629	21,290
Long-Term Investments	276	66	66	76	102	115	134	160
Goodwill	20,386	10,229	10,269	10,107	9,962	10,605	10,408	10,465
Intangible Assets	24,110	11,424	10,747	10,044	9,339	9,626	8,876	8,301
Noncurrent Deferred & Refundable Income Taxes	608	287	464	438	479	584	401	320
Other Noncurrent Operating Assets	3,864	2,326	1,939	1,804	1,687	1,519	1,810	2,044
Total Liabilities & Shareholders' Equity	217,366	42,397	42,649	42,344	42,618	42,996	40,825	42,845
Total Liabilities	67,060	17,842	17,586	16,721	17,077	17,717	16,795	18,459
Total Current Liabilities	26,620	8,238	8,548	9,558	10,744	10,409	10,386	12,125
Short-Term Debt	4,308	7.00	3.00	17	24	198	750	894
Accounts Payable	7,596	3,702	3,615	4,126	4,895	4,280	4,039	4,398
Accrued Expenses	8,010	4,434	2,145	2,068	2,254	2,351	2,103	3,099
Current Deferred Revenue	-	-	2,662	3,201	3,388	3,406	3,287	3,579
Current Deferred & Payable Income Tax Liabilities	372	95	123	146	183	174	207	155
Total Noncurrent Liabilities	40,440	9,604	9,038	7,163	6,333	7,308	6,409	6,334
Long-Term Debt	11,568	115	1,102	1,100	1,283	2,291	1,953	1,686
Noncurrent Deferred & Payable Income Tax Liabilities	2,960	920	893	1,220	1,119	899	478	251
Noncurrent Employee Benefit Liabilities	11,354	6,377	5,176	3,124	2,255	2,467	2,271	2,434
Other Noncurrent Operating Liabilities	3,590	2,192	1,867	1,719	1,676	1,651	1,707	1,963
Total Equity & Noncontrolling Interests	150,306	24,555	25,063	25,623	25,541	25,279	24,030	24,386
Total Preferred & Common Equity	149,559	24,309	24,824	25,384	25,302	25,037	23,789	24,144
Preferred Stock	0.00	-	-	0.00	0.00	0.00	0.00	0.00
Total Common Equity	149,559	24,309	24,824	25,384	25,302	25,037	23,789	24,144
Common Stock	0.00	28,004	27,714	27,758	27,858	27,755	27,203	27,008
Retained Earnings	0.00	-425	-	524	250	-41	55	-67
Accumulated Other Comprehensive Income / (Loss)	-6,720	-3,270	-2,890	-2,898	-2,806	-2,677	-3,469	-2,797
Noncontrolling Interest	747	246	239	239	239	242	241	242

This table presents Corteva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	44,189	43,110	42,996	43,625	41,464	41,908	40,825	42,123	41,759	42,198	42,717
Total Current Assets	17,207	16,333	16,260	17,163	15,359	15,649	15,097	16,587	16,004	16,438	17,385
Cash & Equivalents	2,563	2,254	2,644	1,505	1,839	2,421	3,106	2,008	2,065	2,509	1,964
Short-Term Investments	53	108	98	153	120	72	63	1.00	76	77	2.00
Accounts Receivable	7,955	6,581	5,488	7,906	7,615	6,651	5,676	8,294	8,674	7,784	9,088
Inventories, net	5,628	6,320	6,899	6,183	4,893	5,674	5,432	5,132	4,316	5,310	5,202
Other Current Assets	1,008	1,070	1,131	1,416	892	831	820	1,152	873	758	1,129
Plant, Property, & Equipment, net	4,306	4,320	4,287	4,206	4,155	4,210	4,099	4,105	4,153	4,202	4,183
Plant, Property & Equipment, gross	8,797	8,892	8,956	9,013	9,088	9,235	9,074	9,244	9,455	9,633	9,617
Accumulated Depreciation	4,491	4,572	4,669	4,807	4,933	5,025	4,975	5,139	5,302	5,431	5,434
Total Noncurrent Assets	22,676	22,457	22,449	22,256	21,950	22,049	21,629	21,431	21,602	21,558	21,149
Long-Term Investments	83	106	115	123	113	128	134	136	134	141	165
Goodwill	10,539	10,441	10,605	10,553	10,490	10,629	10,408	10,332	10,518	10,512	10,409
Intangible Assets	9,985	9,795	9,626	9,446	9,238	9,084	8,876	8,718	8,583	8,428	8,147
Noncurrent Deferred & Refundable Income Taxes	524	554	584	551	538	564	401	413	449	434	395
Other Noncurrent Operating Assets	1,545	1,561	1,519	1,583	1,571	1,644	1,810	1,832	1,918	2,043	2,033
Total Liabilities & Shareholders' Equity	44,189	43,110	42,996	43,625	41,464	41,908	40,825	42,123	41,759	42,198	42,717
Total Liabilities	17,728	17,758	17,717	18,617	16,043	16,929	16,795	17,596	15,608	16,737	18,112
Total Current Liabilities	10,346	10,348	10,409	11,332	8,953	10,424	10,386	11,481	9,516	10,420	11,854
Short-Term Debt	3,023	3,724	198	2,148	2,253	3,741	750	2,291	1,942	2,685	1,674
Accounts Payable	3,379	3,678	4,280	3,606	3,300	3,753	4,039	3,905	3,828	4,337	4,187
Accrued Expenses	2,892	2,273	2,351	2,573	2,499	2,188	2,103	2,332	2,903	2,661	2,991
Current Deferred Revenue	656	552	3,406	2,694	413	429	3,287	2,631	358	483	2,773
Current Deferred & Payable Income Tax Liabilities	396	236	174	311	488	313	207	322	485	254	229
Total Noncurrent Liabilities	7,382	7,295	7,308	7,285	7,090	6,505	6,409	6,115	6,092	6,317	6,258
Long-Term Debt	2,290	2,290	2,291	2,492	2,471	1,975	1,953	1,792	1,687	1,688	1,682
Noncurrent Deferred & Payable Income Tax Liabilities	1,134	1,070	899	753	607	496	478	369	258	373	290
Noncurrent Employee Benefit Liabilities	2,236	2,228	2,467	2,453	2,452	2,473	2,271	2,239	2,229	2,215	2,388
Other Noncurrent Operating Liabilities	1,722	1,707	1,651	1,587	1,560	1,561	1,707	1,715	1,918	2,041	1,898
Total Equity & Noncontrolling Interests	26,461	25,467	25,279	25,008	25,421	24,979	24,030	24,527	26,151	25,461	24,605
Total Preferred & Common Equity	26,220	25,226	25,037	24,767	25,179	24,737	23,789	24,285	25,909	25,219	24,362
Preferred Stock	0.00	239	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	26,220	25,226	25,037	24,767	25,179	24,737	23,789	24,285	25,909	25,219	24,362
Common Stock	27,884	27,902	27,755	27,475	27,511	27,525	27,203	26,969	27,021	27,046	26,866
Retained Earnings	1,013	325	-41	302	992	98	55	587	1,532	834	436
Accumulated Other Comprehensive Income / (Loss)	-2,677	-3,001	-2,677	-3,010	-3,324	-2,886	-3,469	-3,271	-2,644	-2,661	-2,940
Noncontrolling Interest	241	241	242	241	242	242	241	242	242	242	243

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-3.09%	2.68%	10.11%	11.50%	-1.31%	-1.85%	2.92%
EBITDA Growth	0.00%	186.50%	11.33%	90.77%	9.17%	-5.14%	5.71%	7.87%
EBIT Growth	0.00%	97.39%	531.14%	230.00%	-36.66%	-11.89%	13.73%	23.87%
NOPAT Growth	0.00%	94.24%	312.77%	40.32%	67.15%	14.44%	-19.87%	42.10%
Net Income Growth	0.00%	81.28%	174.50%	152.35%	-34.54%	-35.49%	23.03%	20.24%
EPS Growth	0.00%	81.07%	171.09%	160.44%	-33.33%	-34.81%	26.21%	23.08%
Operating Cash Flow Growth	0.00%	121.53%	92.90%	32.12%	-37.26%	205.38%	-17.09%	57.25%
Free Cash Flow Firm Growth	0.00%	0.00%	-95.45%	-10.65%	-97.72%	109.92%	5,618.87%	6.96%
Invested Capital Growth	0.00%	-51.80%	-2.34%	-0.84%	5.93%	6.32%	-5.95%	-4.93%
Revenue Q/Q Growth	0.00%	113.31%	34.16%	1.77%	2.02%	-0.68%	1.63%	-0.39%
EBITDA Q/Q Growth	0.00%	-57.15%	-42.09%	9.73%	-3.16%	119.95%	21.50%	-12.74%
EBIT Q/Q Growth	0.00%	-104.31%	-11.00%	15.17%	-21.82%	-6.62%	37.22%	-25.28%
NOPAT Q/Q Growth	0.00%	-107.25%	-3.18%	-4.16%	27.01%	-18.86%	2.54%	-0.61%
Net Income Q/Q Growth	0.00%	-128.66%	51.08%	7.15%	-15.60%	-20.95%	29.99%	-31.58%
EPS Q/Q Growth	0.00%	0.00%	10.98%	7.24%	-15.51%	-21.37%	30.00%	-31.91%
Operating Cash Flow Q/Q Growth	0.00%	11.46%	-3.37%	9.87%	327.53%	103.62%	649.05%	5.37%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-60.48%	5.16%	-12.33%	103.18%	34.07%	6.49%
Invested Capital Q/Q Growth	0.00%	-14.81%	-9.35%	-9.73%	-8.21%	-13.80%	-16.54%	-17.82%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	30.37%	38.07%	40.16%	41.11%	40.21%	42.41%	43.64%	47.29%
EBITDA Margin	-13.79%	12.31%	13.34%	23.12%	22.64%	21.76%	23.43%	24.56%
Operating Margin	-46.45%	-2.76%	3.57%	6.57%	8.97%	10.30%	10.69%	14.01%
EBIT Margin	-44.71%	-1.21%	5.06%	15.18%	8.62%	7.70%	8.92%	10.74%
Profit (Net Income) Margin	-35.19%	-6.80%	4.93%	11.30%	6.63%	4.34%	5.44%	6.35%
Tax Burden Percent	73.86%	297.78%	103.85%	75.40%	81.21%	68.34%	72.08%	65.46%
Interest Burden Percent	106.54%	189.22%	93.75%	98.74%	94.75%	82.43%	84.55%	90.36%
Effective Tax Rate	0.00%	0.00%	-12.00%	22.34%	14.73%	13.91%	32.31%	28.67%
Return on Invested Capital (ROIC)	-9.80%	-0.76%	2.52%	3.59%	5.86%	6.32%	5.06%	7.61%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.43%	0.53%	-3.39%	-27.42%	12.15%	69.30%	68.03%	54.40%
Return on Net Nonoperating Assets (RNNOA)	6.46%	-0.31%	0.31%	3.39%	-1.33%	-3.38%	-1.34%	-3.04%
Return on Equity (ROE)	-3.34%	-1.08%	2.83%	6.98%	4.53%	2.94%	3.73%	4.56%
Cash Return on Invested Capital (CROIC)	0.00%	69.14%	4.89%	4.44%	0.10%	0.20%	11.19%	12.66%
Operating Return on Assets (OROA)	-2.94%	-0.13%	1.69%	5.59%	3.54%	3.10%	3.60%	4.47%
Return on Assets (ROA)	-2.31%	-0.72%	1.65%	4.16%	2.73%	1.75%	2.19%	2.64%
Return on Common Equity (ROCE)	-3.33%	-1.07%	2.80%	6.91%	4.48%	2.91%	3.69%	4.52%
Return on Equity Simple (ROE_SIMPLE)	-3.36%	-3.87%	2.82%	6.97%	4.58%	2.98%	3.86%	0.00%
Net Operating Profit after Tax (NOPAT)	-4,646	-267	569	798	1,335	1,527	1,224	1,739
NOPAT Margin	-32.52%	-1.93%	4.00%	5.10%	7.65%	8.87%	7.24%	9.99%
Net Nonoperating Expense Percent (NNEP)	-0.37%	-1.29%	5.91%	31.01%	-6.29%	-62.98%	-62.97%	-46.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	4.97%	5.50%	4.58%	6.45%
Cost of Revenue to Revenue	69.63%	61.93%	59.84%	58.89%	59.79%	57.59%	56.36%	52.71%
SG&A Expenses to Revenue	21.29%	22.14%	21.40%	20.50%	18.18%	18.44%	18.90%	20.07%
R&D to Revenue	9.48%	8.28%	8.03%	7.58%	6.97%	7.76%	8.29%	8.47%
Operating Expenses to Revenue	76.83%	40.83%	36.59%	34.54%	31.25%	32.11%	32.95%	33.28%
Earnings before Interest and Taxes (EBIT)	-6,388	-167	720	2,376	1,505	1,326	1,508	1,868
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1,970	1,704	1,897	3,619	3,951	3,748	3,962	4,274
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.86	1.12	1.33	1.62	1.33	1.65	1.88
Price to Tangible Book Value (P/TBV)	0.00	7.89	7.31	6.43	6.84	6.95	8.69	8.42
Price to Revenue (P/Rev)	0.00	1.51	1.96	2.15	2.35	1.94	2.32	2.60
Price to Earnings (P/E)	0.00	0.00	40.87	19.13	35.77	45.42	43.16	41.40
Dividend Yield	0.00%	0.93%	1.74%	1.17%	1.27%	1.31%	1.16%	1.04%
Earnings Yield	0.00%	0.00%	2.45%	5.23%	2.80%	2.20%	2.32%	2.42%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.85	1.13	1.37	1.67	1.34	1.66	1.95
Enterprise Value to Revenue (EV/Rev)	0.00	1.41	1.78	1.94	2.24	1.93	2.29	2.50
Enterprise Value to EBITDA (EV/EBITDA)	0.00	11.43	13.34	8.39	9.91	8.87	9.79	10.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	35.16	12.79	26.02	25.08	25.72	23.25
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	44.49	38.05	29.34	21.78	31.70	24.97
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	18.20	12.26	11.14	22.89	6.37	8.95	6.38
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.80	22.93	30.80	1,738.05	703.19	14.34	15.01
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.01	0.04	0.04	0.05	0.10	0.11	0.11
Long-Term Debt to Equity	0.08	0.00	0.04	0.04	0.05	0.09	0.08	0.07
Financial Leverage	-0.68	-0.60	-0.09	-0.12	-0.11	-0.05	-0.02	-0.06
Leverage Ratio	1.45	1.49	1.71	1.68	1.66	1.68	1.70	1.73
Compound Leverage Factor	1.54	2.81	1.61	1.66	1.57	1.39	1.44	1.56
Debt to Total Capital	9.55%	0.49%	4.22%	4.18%	4.87%	8.96%	10.11%	9.57%
Short-Term Debt to Total Capital	2.59%	0.03%	0.01%	0.06%	0.09%	0.71%	2.81%	3.32%
Long-Term Debt to Total Capital	6.96%	0.47%	4.21%	4.11%	4.78%	8.25%	7.31%	6.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.45%	1.00%	0.91%	0.89%	0.89%	0.87%	0.90%	0.90%
Common Equity to Total Capital	90.00%	98.51%	94.86%	94.93%	94.24%	90.16%	88.99%	89.54%
Debt to EBITDA	-8.06	0.07	0.58	0.31	0.33	0.66	0.68	0.60
Net Debt to EBITDA	-5.61	-1.01	-1.45	-0.97	-0.53	-0.10	-0.15	-0.49
Long-Term Debt to EBITDA	-5.87	0.07	0.58	0.30	0.32	0.61	0.49	0.39
Debt to NOPAT	-3.42	-0.46	1.94	1.40	0.98	1.63	2.21	1.48
Net Debt to NOPAT	-2.38	6.41	-4.84	-4.39	-1.58	-0.24	-0.49	-1.21
Long-Term Debt to NOPAT	-2.49	-0.43	1.94	1.38	0.96	1.50	1.60	0.97
Altman Z-Score	0.00	1.15	1.51	1.95	2.15	1.79	2.08	2.17
Noncontrolling Interest Sharing Ratio	0.50%	0.57%	0.98%	0.94%	0.93%	0.95%	0.98%	1.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.73	1.64	1.73	1.63	1.56	1.56	1.45	1.43
Quick Ratio	0.57	0.89	1.02	0.98	0.84	0.79	0.85	0.90
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	24,281	1,104	986	23	47	2,705	2,893
Operating Cash Flow to CapEx	32.18%	92.00%	434.53%	475.92%	141.41%	439.08%	362.81%	576.31%
Free Cash Flow to Firm to Interest Expense	0.00	162.96	24.53	32.88	0.29	0.20	11.61	16.07
Operating Cash Flow to Interest Expense	1.16	7.18	45.87	90.90	21.66	22.42	18.59	37.84
Operating Cash Flow Less CapEx to Interest Expense	-2.44	-0.62	35.31	71.80	6.34	17.32	13.47	31.28
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.07	0.11	0.33	0.37	0.41	0.40	0.40	0.42
Accounts Receivable Turnover	1.36	1.73	2.72	3.22	3.32	3.08	3.03	2.89
Inventory Turnover	0.94	1.10	1.72	1.83	1.74	1.45	1.55	1.65
Fixed Asset Turnover	1.57	2.03	3.18	3.59	4.07	4.03	4.03	4.18
Accounts Payable Turnover	1.31	1.52	2.33	2.38	2.31	2.16	2.29	2.17
Days Sales Outstanding (DSO)	268.76	211.52	134.20	113.51	109.91	118.54	120.50	126.35
Days Inventory Outstanding (DIO)	389.66	333.12	212.68	199.17	209.69	252.23	236.16	220.84
Days Payable Outstanding (DPO)	278.70	240.45	156.97	153.22	157.76	168.79	159.33	167.88
Cash Conversion Cycle (CCC)	379.71	304.19	189.91	159.45	161.85	201.97	197.34	179.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	47,390	22,842	22,307	22,119	23,431	24,911	23,430	22,276
Invested Capital Turnover	0.30	0.39	0.63	0.70	0.77	0.71	0.70	0.76
Increase / (Decrease) in Invested Capital	0.00	-24,548	-535	-188	1,312	1,480	-1,481	-1,154
Enterprise Value (EV)	0.00	19,477	25,314	30,377	39,159	33,258	38,789	43,426
Market Capitalization	0.00	20,944	27,831	33,642	41,030	33,384	39,148	45,294
Book Value per Share	$0.00	$32.48	$33.32	$34.82	$35.41	$35.53	$34.61	$35.73
Tangible Book Value per Share	$0.00	$3.55	$5.11	$7.18	$8.40	$6.82	$6.55	$7.96
Total Capital	166,182	24,677	26,168	26,740	26,848	27,768	26,733	26,966
Total Debt	15,876	122	1,105	1,117	1,307	2,489	2,703	2,580
Total Long-Term Debt	11,568	115	1,102	1,100	1,283	2,291	1,953	1,686
Net Debt	11,050	-1,713	-2,756	-3,504	-2,110	-368	-600	-2,110
Capital Expenditures (CapEx)	1,501	1,163	475	573	1,210	1,190	1,194	1,182
Debt-free, Cash-free Net Working Capital (DFCFNWC)	19,082	3,519	2,428	1,460	2,760	3,307	2,292	1,574
Debt-free Net Working Capital (DFNWC)	23,632	5,288	6,223	6,005	6,075	6,049	5,461	6,104
Net Working Capital (NWC)	19,324	5,281	6,220	5,988	6,051	5,851	4,711	5,210
Net Nonoperating Expense (NNE)	381	674	-132	-971	177	780	305	634
Net Nonoperating Obligations (NNO)	-102,916	-1,713	-2,756	-3,504	-2,110	-368	-600	-2,110
Total Depreciation and Amortization (D&A)	4,418	1,871	1,177	1,243	2,446	2,422	2,454	2,406
Debt-free, Cash-free Net Working Capital to Revenue	133.56%	25.42%	17.08%	9.33%	15.81%	19.20%	13.56%	9.05%
Debt-free Net Working Capital to Revenue	165.41%	38.19%	43.77%	38.36%	34.80%	35.12%	32.30%	35.08%
Net Working Capital to Revenue	135.26%	38.14%	43.75%	38.25%	34.67%	33.97%	27.86%	29.94%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.76)	($1.28)	$0.91	$2.39	$1.59	$1.04	$1.31	$1.60
Adjusted Weighted Average Basic Shares Outstanding	0.00	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Adjusted Diluted Earnings per Share	($6.76)	($1.28)	$0.91	$2.37	$1.58	$1.03	$1.30	$1.60
Adjusted Weighted Average Diluted Shares Outstanding	0.00	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Adjusted Basic & Diluted Earnings per Share	($6.76)	($1.28)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	749.40M	744.06M	727.02M	712.82M	701.78M	685.56M	672.52M
Normalized Net Operating Profit after Tax (NOPAT)	-1,008	-112	590	1,023	1,644	1,817	1,419	1,843
Normalized NOPAT Margin	-7.06%	-0.81%	4.15%	6.53%	9.42%	10.55%	8.39%	10.59%
Pre Tax Income Margin	-47.64%	-2.28%	4.75%	14.99%	8.17%	6.35%	7.54%	9.70%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-15.28	-1.12	16.00	79.20	19.05	5.69	6.47	10.38
NOPAT to Interest Expense	-11.11	-1.79	12.64	26.61	16.89	6.55	5.25	9.66
EBIT Less CapEx to Interest Expense	-18.87	-8.93	5.44	60.10	3.73	0.58	1.35	3.81
NOPAT Less CapEx to Interest Expense	-14.71	-9.60	2.09	7.51	1.58	1.45	0.13	3.09
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-55.82%	54.30%	63.91%	22.44%	36.10%	58.77%	254.30%	195.20%
Augmented Payout Ratio	-55.82%	51.65%	103.14%	76.14%	122.45%	159.97%	364.09%	292.13%

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	672,163,200.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	672,163,200.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.07
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.73%	-3.09%	-8.03%	1.11%	-10.19%	7.31%	-1.67%	5.63%	12.55%	-1.71%	11.05%
EBITDA Growth	60.00%	186.17%	17.58%	51.34%	156.25%	-40.41%	24.19%	21.20%	513.33%	-82.98%	5.38%
EBIT Growth	-2.12%	-56.29%	-35.19%	20.41%	-46.89%	156.71%	56.79%	32.19%	42.86%	-427.03%	9.02%
NOPAT Growth	40.90%	-509.18%	-29.35%	13.45%	-94.09%	37.30%	41.15%	12.17%	34.57%	272.86%	24.74%
Net Income Growth	3.05%	-373.58%	-29.38%	47.28%	-63.84%	84.46%	55.08%	24.62%	38.96%	-1,307.69%	10.21%
EPS Growth	2.17%	-400.00%	-27.71%	51.00%	-68.89%	85.71%	58.33%	27.15%	38.16%	-1,500.00%	12.63%
Operating Cash Flow Growth	96.08%	30.29%	-68.65%	-33.99%	-8.57%	21.27%	19.23%	111.15%	51.97%	4.13%	-37.08%
Free Cash Flow Firm Growth	-170.80%	-19.96%	162.53%	181.40%	114.20%	188.15%	25.17%	-13.11%	50.66%	-9.02%	-28.64%
Invested Capital Growth	13.20%	6.32%	-4.07%	-3.45%	-2.85%	-5.95%	-5.03%	-2.02%	-3.44%	-4.93%	-2.40%
Revenue Q/Q Growth	-57.15%	43.13%	21.18%	36.06%	-61.94%	71.02%	11.04%	46.16%	-59.45%	49.35%	25.45%
EBITDA Q/Q Growth	-105.97%	1,677.50%	234.08%	78.36%	-97.78%	1,571.11%	87.77%	74.08%	-88.77%	-53.62%	1,062.50%
EBIT Q/Q Growth	-133.10%	32.38%	300.38%	168.45%	-140.38%	126.10%	454.05%	126.34%	-117.46%	-49.38%	284.71%
NOPAT Q/Q Growth	-115.72%	29.54%	376.75%	146.75%	-126.89%	77.24%	1,034.39%	96.09%	-115.69%	160.13%	574.26%
Net Income Q/Q Growth	-144.35%	21.07%	268.53%	149.65%	-149.34%	92.51%	1,782.05%	100.61%	-124.16%	-72.64%	231.69%
EPS Q/Q Growth	-145.00%	22.22%	271.43%	151.67%	-150.33%	93.42%	2,000.00%	102.11%	-124.48%	-70.21%	233.75%
Operating Cash Flow Q/Q Growth	-112.93%	7,556.19%	-179.91%	109.60%	-121.27%	8,428.07%	-144.43%	144.90%	-79.62%	2,166.84%	-166.08%
Free Cash Flow Firm Q/Q Growth	-30.88%	54.84%	200.72%	31.91%	-77.17%	180.42%	48.25%	-8.43%	-60.42%	69.34%	16.29%
Invested Capital Q/Q Growth	-0.61%	-13.80%	11.87%	0.74%	0.00%	-16.54%	12.95%	3.93%	-1.45%	-17.82%	15.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.45%	36.17%	43.23%	52.26%	32.72%	37.25%	46.98%	54.58%	37.20%	42.35%	51.64%
EBITDA Margin	-3.09%	34.04%	25.31%	33.18%	1.93%	18.90%	31.97%	38.07%	10.54%	3.27%	30.34%
Operating Margin	-9.15%	-4.51%	13.85%	24.82%	-19.78%	3.24%	18.23%	27.15%	-11.50%	4.63%	20.61%
EBIT Margin	-14.90%	-7.04%	11.64%	22.97%	-24.38%	3.72%	18.56%	28.75%	-12.38%	-12.38%	18.23%
Profit (Net Income) Margin	-12.28%	-6.77%	9.42%	17.28%	-22.40%	-0.98%	14.85%	20.38%	-12.15%	-14.04%	14.74%
Tax Burden Percent	71.62%	77.71%	87.76%	78.92%	82.31%	-44.32%	83.67%	72.95%	85.95%	103.58%	84.27%
Interest Burden Percent	115.03%	123.75%	92.16%	95.30%	111.64%	59.46%	95.61%	97.20%	114.20%	109.50%	95.97%
Effective Tax Rate	0.00%	0.00%	21.99%	21.08%	0.00%	156.82%	14.92%	23.39%	0.00%	0.00%	15.50%
Return on Invested Capital (ROIC)	-4.08%	-2.25%	6.39%	11.59%	-8.09%	-1.29%	9.61%	12.86%	-5.10%	2.47%	11.92%
ROIC Less NNEP Spread (ROIC-NNEP)	-11.93%	8.58%	4.34%	6.22%	-14.18%	-8.37%	8.40%	11.51%	-9.62%	52.33%	3.61%
Return on Net Nonoperating Assets (RNNOA)	-0.91%	-0.42%	0.52%	0.63%	-1.83%	0.16%	0.81%	0.89%	-0.90%	-2.93%	0.23%
Return on Equity (ROE)	-5.00%	-2.67%	6.91%	12.22%	-9.92%	-1.12%	10.42%	13.75%	-6.00%	-0.46%	12.15%
Cash Return on Invested Capital (CROIC)	-5.47%	0.20%	8.89%	8.62%	7.08%	11.19%	10.52%	7.85%	9.85%	12.66%	9.67%
Operating Return on Assets (OROA)	-6.17%	-2.83%	4.40%	9.07%	-9.54%	1.50%	7.29%	11.87%	-5.14%	-5.15%	7.69%
Return on Assets (ROA)	-5.08%	-2.72%	3.56%	6.82%	-8.77%	-0.40%	5.83%	8.41%	-5.05%	-5.84%	6.22%
Return on Common Equity (ROCE)	-4.95%	-2.64%	6.84%	12.10%	-9.83%	-1.11%	10.32%	13.62%	-5.94%	-0.46%	12.03%
Return on Equity Simple (ROE_SIMPLE)	3.75%	0.00%	2.31%	3.61%	2.86%	0.00%	4.74%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-166	-117	485	1,197	-322	-73	685	1,343	-211	127	854
NOPAT Margin	-6.41%	-3.15%	10.80%	19.59%	-13.84%	-1.84%	15.51%	20.80%	-8.05%	3.24%	17.42%
Net Nonoperating Expense Percent (NNEP)	7.85%	-10.82%	2.05%	5.37%	6.10%	7.09%	1.20%	1.34%	4.53%	-49.87%	8.30%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.42%	-	-	-	-0.27%	2.39%	4.51%	-0.71%	0.47%	3.06%
Cost of Revenue to Revenue	63.55%	63.83%	56.77%	47.74%	67.28%	62.75%	53.02%	45.42%	62.80%	57.65%	48.36%
SG&A Expenses to Revenue	25.87%	19.83%	16.38%	17.24%	28.85%	18.48%	17.00%	17.91%	27.69%	21.99%	17.88%
R&D to Revenue	12.93%	9.63%	7.39%	5.84%	14.96%	9.18%	7.58%	5.81%	13.41%	10.56%	6.95%
Operating Expenses to Revenue	45.60%	40.68%	29.39%	27.44%	52.49%	34.01%	28.75%	27.43%	48.70%	37.72%	31.03%
Earnings before Interest and Taxes (EBIT)	-386	-261	523	1,404	-567	148	820	1,856	-324	-484	894
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-80	1,262	1,137	2,028	45	752	1,412	2,458	276	128	1,488
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.42	1.33	1.64	1.49	1.65	1.65	1.78	1.96	1.82	1.88	2.31
Price to Tangible Book Value (P/TBV)	7.19	6.95	8.52	6.90	8.10	8.69	8.24	7.47	7.31	8.42	9.69
Price to Revenue (P/Rev)	2.07	1.94	2.41	2.22	2.45	2.32	2.56	2.96	2.63	2.60	3.15
Price to Earnings (P/E)	38.44	45.42	72.70	41.87	58.56	43.16	37.84	36.29	28.62	41.40	48.42
Dividend Yield	1.50%	1.31%	1.09%	1.19%	1.11%	1.16%	1.06%	0.91%	1.02%	1.04%	0.85%
Earnings Yield	2.60%	2.20%	1.38%	2.39%	1.71%	2.32%	2.64%	2.76%	3.49%	2.42%	2.07%
Enterprise Value to Invested Capital (EV/IC)	1.38	1.34	1.57	1.44	1.58	1.66	1.71	1.91	1.76	1.95	2.24
Enterprise Value to Revenue (EV/Rev)	2.30	1.93	2.60	2.40	2.66	2.29	2.69	3.05	2.74	2.50	3.23
Enterprise Value to EBITDA (EV/EBITDA)	23.41	8.87	25.11	12.91	13.58	9.79	10.70	11.24	9.76	10.16	13.27
Enterprise Value to EBIT (EV/EBIT)	28.09	25.08	41.98	31.63	40.29	25.72	25.11	23.23	19.13	23.25	29.73
Enterprise Value to NOPAT (EV/NOPAT)	21.19	21.78	32.43	27.74	37.10	31.70	31.11	32.50	27.33	24.97	30.49
Enterprise Value to Operating Cash Flow (EV/OCF)	15.55	6.37	0.00	0.00	0.00	8.95	8.49	8.28	7.40	6.38	11.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	703.19	17.28	16.45	21.94	14.34	15.85	24.04	17.60	15.01	22.83
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.24	0.10	0.19	0.19	0.23	0.11	0.17	0.14	0.17	0.11	0.14
Long-Term Debt to Equity	0.09	0.09	0.10	0.10	0.08	0.08	0.07	0.06	0.07	0.07	0.07
Financial Leverage	0.08	-0.05	0.12	0.10	0.13	-0.02	0.10	0.08	0.09	-0.06	0.06
Leverage Ratio	1.66	1.68	1.75	1.65	1.69	1.70	1.73	1.61	1.67	1.73	1.73
Compound Leverage Factor	1.91	2.08	1.62	1.57	1.88	1.01	1.66	1.57	1.90	1.89	1.66
Debt to Total Capital	19.10%	8.96%	15.65%	15.67%	18.62%	10.11%	14.27%	12.19%	14.66%	9.57%	12.00%
Short-Term Debt to Total Capital	11.83%	0.71%	7.25%	7.47%	12.19%	2.81%	8.01%	6.52%	9.00%	3.32%	5.99%
Long-Term Debt to Total Capital	7.27%	8.25%	8.41%	8.20%	6.43%	7.31%	6.26%	5.66%	5.66%	6.25%	6.02%
Preferred Equity to Total Capital	0.76%	0.00%	0.00%	0.00%	0.78%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.77%	0.87%	0.81%	0.80%	0.79%	0.90%	0.85%	0.81%	0.81%	0.90%	0.87%
Common Equity to Total Capital	80.13%	90.16%	83.54%	83.53%	80.59%	88.99%	84.88%	87.00%	84.53%	89.54%	87.13%
Debt to EBITDA	3.53	0.66	2.66	1.51	1.75	0.68	0.96	0.78	0.89	0.60	0.77
Net Debt to EBITDA	2.08	-0.10	1.64	0.85	0.95	-0.15	0.46	0.29	0.34	-0.49	0.28
Long-Term Debt to EBITDA	1.34	0.61	1.43	0.79	0.61	0.49	0.42	0.36	0.34	0.39	0.39
Debt to NOPAT	3.20	1.63	3.44	3.24	4.79	2.21	2.80	2.25	2.50	1.48	1.77
Net Debt to NOPAT	1.88	-0.24	2.12	1.82	2.59	-0.49	1.33	0.84	0.94	-1.21	0.65
Long-Term Debt to NOPAT	1.22	1.50	1.85	1.69	1.65	1.60	1.23	1.05	0.96	0.97	0.89
Altman Z-Score	1.76	1.67	1.91	2.14	1.95	1.97	2.10	2.75	2.23	1.98	2.52
Noncontrolling Interest Sharing Ratio	0.95%	0.95%	0.95%	0.93%	0.96%	0.98%	0.98%	0.94%	0.96%	1.00%	0.99%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.58	1.56	1.51	1.72	1.50	1.45	1.44	1.68	1.58	1.43	1.47
Quick Ratio	0.86	0.79	0.84	1.07	0.88	0.85	0.90	1.14	1.00	0.90	0.93
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,536	-1,597	1,667	2,199	502	1,408	2,087	1,911	756	1,281	1,489
Operating Cash Flow to CapEx	-64.81%	1,006.30%	-1,886.49%	235.09%	-37.01%	2,622.65%	-2,243.62%	802.54%	122.93%	1,970.72%	-3,569.14%
Free Cash Flow to Firm to Interest Expense	-60.96	-25.76	40.66	33.32	7.61	23.46	57.97	36.75	16.44	27.84	41.37
Operating Cash Flow to Interest Expense	-1.81	126.27	-136.20	8.12	-1.73	158.23	-117.17	36.42	8.39	190.22	-160.61
Operating Cash Flow Less CapEx to Interest Expense	-4.60	113.73	-143.41	4.67	-6.39	152.20	-122.39	31.88	1.57	180.57	-165.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.40	0.38	0.39	0.39	0.40	0.39	0.41	0.42	0.42	0.42
Accounts Receivable Turnover	2.70	3.08	2.03	2.17	2.51	3.03	2.08	2.11	2.42	2.89	2.06
Inventory Turnover	1.72	1.45	1.52	1.80	1.57	1.55	1.65	2.03	1.71	1.65	1.78
Fixed Asset Turnover	4.08	4.03	3.97	4.00	3.90	4.03	4.05	4.14	4.15	4.18	4.32
Accounts Payable Turnover	2.57	2.16	2.56	2.84	2.53	2.29	2.48	2.62	2.33	2.17	2.27
Days Sales Outstanding (DSO)	135.25	118.54	179.79	168.13	145.15	120.50	175.64	173.07	150.80	126.35	177.33
Days Inventory Outstanding (DIO)	212.80	252.23	240.25	202.54	232.89	236.16	221.54	180.04	212.94	220.84	204.95
Days Payable Outstanding (DPO)	141.77	168.79	142.31	128.58	144.29	159.33	147.06	139.35	156.83	167.88	160.49
Cash Conversion Cycle (CCC)	206.29	201.97	277.73	242.09	233.75	197.34	250.12	213.75	206.91	179.32	221.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	28,898	24,911	27,867	28,073	28,074	23,430	26,465	27,505	27,107	22,276	25,830
Invested Capital Turnover	0.64	0.71	0.59	0.59	0.58	0.70	0.62	0.62	0.63	0.76	0.68
Increase / (Decrease) in Invested Capital	3,370	1,480	-1,182	-1,002	-824	-1,481	-1,402	-568	-967	-1,154	-635
Enterprise Value (EV)	39,893	33,258	43,742	40,489	44,273	38,789	45,322	52,438	47,816	43,426	57,735
Market Capitalization	35,867	33,384	40,642	37,595	40,697	39,148	43,142	50,842	45,928	45,294	56,267
Book Value per Share	$35.54	$35.53	$35.53	$36.13	$35.73	$34.61	$35.42	$37.98	$37.14	$35.73	$36.24
Tangible Book Value per Share	$7.03	$6.82	$6.84	$7.82	$7.26	$6.55	$7.64	$9.98	$9.25	$7.96	$8.64
Total Capital	31,481	27,768	29,648	30,145	30,695	26,733	28,610	29,780	29,834	26,966	27,961
Total Debt	6,014	2,489	4,640	4,724	5,716	2,703	4,083	3,629	4,373	2,580	3,356
Total Long-Term Debt	2,290	2,291	2,492	2,471	1,975	1,953	1,792	1,687	1,688	1,686	1,682
Net Debt	3,546	-368	2,859	2,652	3,095	-600	1,938	1,354	1,646	-2,110	1,225
Capital Expenditures (CapEx)	162	778	296	228	308	362	188	236	314	444	162
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7,347	3,307	6,321	6,700	6,473	2,292	5,388	6,289	6,117	1,574	5,239
Debt-free Net Working Capital (DFNWC)	9,709	6,049	7,979	8,659	8,966	5,461	7,397	8,430	8,703	6,104	7,205
Net Working Capital (NWC)	5,985	5,851	5,831	6,406	5,225	4,711	5,106	6,488	6,018	5,210	5,531
Net Nonoperating Expense (NNE)	152	134	62	141	199	-34	29	27	107	676	131
Net Nonoperating Obligations (NNO)	3,431	-368	2,859	2,652	3,095	-600	1,938	1,354	1,646	-2,110	1,225
Total Depreciation and Amortization (D&A)	306	1,523	614	624	612	604	592	602	600	612	594
Debt-free, Cash-free Net Working Capital to Revenue	42.36%	19.20%	37.55%	39.64%	38.91%	13.56%	32.01%	36.61%	35.02%	9.05%	29.29%
Debt-free Net Working Capital to Revenue	55.98%	35.12%	47.40%	51.23%	53.89%	32.30%	43.94%	49.08%	49.82%	35.08%	40.28%
Net Working Capital to Revenue	34.51%	33.97%	34.64%	37.90%	31.41%	27.86%	30.33%	37.77%	34.45%	29.94%	30.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.45)	($0.35)	$0.60	$1.51	($0.76)	($0.04)	$0.95	$1.92	($0.47)	($0.80)	$1.07
Adjusted Weighted Average Basic Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Adjusted Diluted Earnings per Share	($0.45)	($0.35)	$0.60	$1.51	($0.76)	($0.05)	$0.95	$1.92	($0.47)	($0.80)	$1.07
Adjusted Weighted Average Diluted Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	704.73M	701.78M	696.98M	692.25M	687.29M	685.56M	682.17M	679.10M	675.73M	672.52M	668.82M
Normalized Net Operating Profit after Tax (NOPAT)	-165	52	544	1,270	-300	153	704	1,403	-190	137	932
Normalized NOPAT Margin	-6.35%	1.40%	12.10%	20.78%	-12.88%	3.84%	15.93%	21.74%	-7.25%	3.51%	19.00%
Pre Tax Income Margin	-17.14%	-8.71%	10.73%	21.89%	-27.21%	2.21%	17.75%	27.94%	-14.13%	-13.56%	17.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-6.66	-4.21	12.76	21.27	-8.59	2.47	22.78	35.69	-7.04	-10.52	24.83
NOPAT to Interest Expense	-2.86	-1.89	11.83	18.14	-4.88	-1.22	19.02	25.83	-4.58	2.75	23.73
EBIT Less CapEx to Interest Expense	-9.45	-16.76	5.54	17.82	-13.26	-3.57	17.56	31.15	-13.87	-20.17	20.33
NOPAT Less CapEx to Interest Expense	-5.65	-14.43	4.61	14.69	-9.55	-7.25	13.80	21.29	-11.41	-6.90	19.23
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	45.93%	58.77%	77.76%	49.34%	63.93%	254.30%	247.74%	229.04%	223.59%	195.20%	172.35%
Augmented Payout Ratio	128.99%	159.97%	210.16%	151.32%	195.19%	364.09%	336.89%	301.63%	286.87%	292.13%	262.03%

Financials Breakdown Chart

Key Financial Trends

Corteva (CTVA) has shown a solid scale and a strong cash-generation profile in many quarters, along with a sizable equity base. While revenue and earnings have been somewhat volatile across quarters, the company consistently parks meaningful operating cash flow and maintains a durable balance sheet. Cash returns to shareholders via dividends have been a feature, while financing activity has often shown net cash outflows as the company funds buybacks and distributions. Below are the key trends from the last four years of quarterly data, highlighting the main positives, neutrals, and potential negatives.

Strong quarterly operating cash flow in late 2024 and 2025: Net Cash From Operating Activities was about $9.49B in Q4 2024 and $8.75B in Q4 2025, underscoring robust cash generation.
Positive net income per share in a key trough quarter: Net income attributable to common shareholders was $1.314B in Q2 2025, indicating a period of earnings strength within a volatile pattern.
Shareholder returns via a notable dividend per share: The company declared cash dividends per share of $0.17 in Q1 2025, demonstrating ongoing capital return to stockholders.
Solid balance sheet with a large asset base and substantial equity: Total assets around $41–42B and Total equity around $25–26B in 2025, providing financial flexibility against downside scenarios.
Stable revenue scale across quarters in the mid-range of recent years: Quarterly operating revenue generally sits in the $3.9–4.4B range (e.g., Q4 2025 $3.91B; Q1 2025 $4.42B), indicating a persistent base level of activity.
Reasonable short-term liquidity based on the balance sheet mix: In mid-2025, Total Current Assets (~$16–17B) exceeded Total Current Liabilities (~$9–11B), suggesting a comfortable liquidity cushion for near-term obligations.
Moderate, steady capital expenditure: Quarterly purchases of PPE run around $0.2–0.4B, supporting continued capacity without excessive spending.
Seasonality and quarterly volatility observed in revenue: Notable revenue spikes (e.g., Q2 2025) and troughs suggest seasonality and quarterly swings rather than a straight growth path.

Recent quarters show negative earnings for common shareholders: Q4 2025 net income attributable to common shareholders was -$552M, reflecting earnings headwinds and mix changes within the period.
Some quarters show significant operating cash flow swings, including a large negative quarter: Q1 2025 net cash from operating activities was -$4.22B, indicating substantial working capital or timing effects that diluted quarterly cash flow.

05/22/26 01:02 PM ETAI Generated. May Contain Errors.

Corteva Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Corteva's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Corteva's net income appears to be on an upward trend, with a most recent value of $1.11 billion in 2025, falling from -$5.03 billion in 2018. The previous period was $919 million in 2024. View Corteva's forecast to see where analysts expect Corteva to go next.

Corteva's total operating income in 2025 was $2.44 billion, based on the following breakdown:

Total Gross Profit: $8.23 billion
Total Operating Expenses: $5.79 billion

Over the last 7 years, Corteva's total revenue changed from $14.29 billion in 2018 to $17.40 billion in 2025, a change of 21.8%.

Corteva's total liabilities were at $18.46 billion at the end of 2025, a 9.9% increase from 2024, and a 72.5% decrease since 2018.

In the past 7 years, Corteva's cash and equivalents has ranged from $1.76 billion in 2019 to $4.54 billion in 2018, and is currently $4.52 billion as of their latest financial filing in 2025.

Over the last 7 years, Corteva's book value per share changed from 0.00 in 2018 to 35.73 in 2025, a change of 3,573.0%.

Related Companies

Financial statements for NYSE:CTVA last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Financials

Financials Breakdown Chart

Key Financial Trends

Corteva Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Corteva (CTVA) Financials

Annual Income Statements for Corteva

Quarterly Income Statements for Corteva

Annual Cash Flow Statements for Corteva

Quarterly Cash Flow Statements for Corteva

Annual Balance Sheets for Corteva

Quarterly Balance Sheets for Corteva

Annual Metrics And Ratios for Corteva

Quarterly Metrics And Ratios for Corteva

Financials Breakdown Chart

Key Financial Trends

Corteva Financials - Frequently Asked Questions

When does Corteva's fiscal year end?

How has Corteva's net income changed over the last 7 years?

What is Corteva's operating income?

How has Corteva's revenue changed over the last 7 years?

How much debt does Corteva have?

How much cash does Corteva have?

How has Corteva's book value per share changed over the last 7 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools